| CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers (NCT02355262) | OHSU Knight Cancer Institute | 2014-07-01 |
| Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps (NCT02134925) | National Cancer Institute (NCI) | 2014-06-23 |
| Latinos CARES (Colorectal Cancer Awareness, Research, Education and Screening) (NCT03078361) | H. Lee Moffitt Cancer Center and Research Institute | 2014-04-28 |
| Accuracy of the Optical Diagnosis of Small Colonic Polyps Using the Nice Classification (NCT02009774) | Technical University of Munich | 2014-01-01 |
| A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors (NCT02009449) | Eli Lilly and Company | 2013-11-15 |
| Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy (NCT02694562) | Boston Scientific Corporation | 2013-11-01 |
| BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Pretreated Advanced Colorectal Carcinoma (NCT01830621) | NCIC Clinical Trials Group | 2013-05-10 |
| An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to Metformin (NCT01816659) | M.D. Anderson Cancer Center | 2013-05-01 |
| Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI) (NCT01671592) | Pawel Kalinski | 2013-01-01 |
| Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer (NCT01545141) | Roswell Park Cancer Institute | 2012-10-01 |
| ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer (NCT01675128) | National Cancer Institute (NCI) | 2012-08-01 |
| Lay Health Worker Outreach in Increasing Colorectal Cancer Screening in Asian Americans (NCT03115372) | University of California, San Francisco | 2012-02-01 |
| Axitinib as Maintenance Treatment in Patients With Metastatic CRC (NCT01483638) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2012-02-01 |
| Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma (NCT01394939) | Jennerex Biotherapeutics | 2012-01-01 |
| Increasing Access to Colorectal Cancer Testing (IACCT) for Blacks (NCT03078348) | H. Lee Moffitt Cancer Center and Research Institute | 2011-12-05 |
| A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin (NCT01157039) | AHS Cancer Control Alberta | 2011-10-01 |
| Neoadjuvant Study of Recombinant Vaccinia Virus to Treat Metastatic Colorectal Carcinoma in Patients Undergoing Complete Resection of Liver Tumors (NCT01329809) | Jennerex Biotherapeutics | 2011-10-01 |
| Assessment of Tumor Vascular Effects of Axitinib With Dynamic Ultrasonography in Patients With Metastatic Colorectal Cancer (NCT01486251) | Gustave Roussy, Cancer Campus, Grand Paris | 2011-09-01 |
| KRAS Mutation and Incidence of the Colorectal Carcinoma in Martinique Between 2007 and 2009 (NCT01151007) | University Hospital Center of Martinique | 2011-07-01 |
| Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin (NCT01466504) | Dartmouth-Hitchcock Medical Center | 2011-05-01 |
| Comparative Study of Lubiprostone and PEG Preparation Versus Conventional PEG Preparation for Colonoscopy (NCT01324284) | Asian Institute of Gastroenterology, India | 2011-03-01 |
| A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B) (NCT01286818) | Eli Lilly and Company | 2011-02-01 |
| Enteropathogenic Escherichia Coli (EPEC): Does it Have a Role in Colorectal Tumourigenesis? (NCT02373020) | Mansoura University | 2011-01-01 |
| Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma (NCT01348256) | Clinica Universidad de Navarra, Universidad de Navarra | 2010-11-01 |
| Physical Activity for Reduction of Recurrence Rate After Adjuvant Chemotherapy for Localised Colorectal Carcinoma (NCT01210313) | Austrian Breast & Colorectal Cancer Study Group | 2010-10-01 |
| Radiofrequency Ablation Versus Stereotactic Radiotherapy in Colorectal Liver Metastases (NCT01233544) | University of Aarhus | 2010-09-01 |
| Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer (NCT01139138) | The Queen Elizabeth Hospital | 2010-06-01 |
| Improvement of Fluid Balance in Patients Undergoing Surgery of the Colon and Rectum (NCT01175317) | Maastricht University Medical Center | 2010-04-01 |
| Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiation in Patients With Colorectal Carcinoma (NCT00725400) | American Scitech International | 2010-02-01 |
| Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases (NCT01095523) | National Cancer Institute (NCI) | 2010-01-14 |
| The Effect of Environmental Pollution on Colorectal Cancer (NCT06686953) | Dong Peng | 2010-01-01 |
| Macrogol 3350-based Oral Osmotic Laxative in Preventing Cancer in Patients at Risk of Colorectal Cancer (NCT00828984) | National Cancer Institute (NCI) | 2009-10-01 |
| Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies (NCT02073500) | Oslo University Hospital | 2009-09-01 |
| Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy (NCT01126866) | National Center for Tumor Diseases, Heidelberg | 2009-06-01 |
| A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer (NCT00862784) | Eli Lilly and Company | 2009-04-01 |
| Nelfinavir, a Phase I/Phase II Rectal Cancer Study (NCT00704600) | Maastricht Radiation Oncology | 2008-09-01 |
| FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma (NCT00735241) | Sirtex Medical | 2008-07-01 |
| IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101) (NCT00785122) | Immatics Biotechnologies GmbH | 2008-06-01 |
| Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms (NCT01640522) | University of Pittsburgh | 2008-01-01 |
| A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer (NCT00478634) | Novartis Pharmaceuticals | 2007-05-01 |
| A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal Cancer (NCT00437268) | Eli Lilly and Company | 2007-03-01 |
| Safety Study of PLX4032 in Patients With Solid Tumors (NCT00405587) | Plexxikon | 2006-11-01 |
| Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003 (NCT00405561) | Auron Healthcare GmbH | 2006-10-01 |
| FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer (NCT00724503) | Sirtex Medical | 2006-08-01 |
| SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer (NCT00361244) | Massachusetts General Hospital | 2006-07-01 |
| Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer (NCT00288444) | Emory University | 2006-01-01 |
| Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy. (NCT00305188) | Sanofi | 2005-12-01 |
| A Phase II Study of Cetuximab Plus Irinotecan in Patients With EGFR-detectable Metastatic Colorectal Carcinoma (NCT00362102) | Eli Lilly and Company | 2005-10-01 |
| XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer (NCT00215722) | Grupo de Investigacao do Cancro Digestivo | 2005-07-01 |
| Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases (NCT00107861) | Biogen | 2005-05-01 |
| Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer (NCT00199862) | Memorial Sloan Kettering Cancer Center | 2004-02-01 |
| Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma (NCT00051987) | Millennium Pharmaceuticals, Inc. | 2002-12-01 |
| XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy (NCT00272051) | Sanofi | 2002-07-01 |
| Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer (NCT00179348) | Albert Einstein College of Medicine | 2001-02-08 |
| Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma (NCT00176774) | University of Michigan Rogel Cancer Center | 2001-02-01 |
| Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer (NCT00041652) | Gilead Sciences | 2000-02-01 |
| Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies (NCT06978595) | asmaa salama ibrahim | 2000-01-01 |
| Utility of PET In the Pre-Operative Assessment of Patients With Hepatic Colorectal Metastases (NCT00588549) | Memorial Sloan Kettering Cancer Center | 1998-07-01 |
| Laparoscopic Assisted Versus Open Resection for Colorectal Carcinoma (NCT00485316) | Chinese University of Hong Kong | 1993-09-01 |
| A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome (NCT01286662) | Triemli Hospital | 1978-01-01 |